Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 19(1)2018 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-29324683

RESUMO

Renal ischemia-reperfusion injury (IRI) induces local inflammation leading to kidney damage. Since pentoxifylline (PTX) and steroids have distinct immunomodulatory properties, we aimed to evaluate for the first time their combined use in IRI-induced acute kidney injury (AKI) and chronic kidney disease (CKD) in rats. In two experiments, PTX (100 mg/kg body weight subcutaneously) was administered 90 min prior to renal IRI or/and methylprednisolone (MP; 100 mg/kg body weight intramuscularly) was infused 60 min after reperfusion of a solitary kidney (AKI model: 45 min ischemia, 48 male Sprague-Dawley rats) or one kidney with excision of contralateral kidney 2 weeks later (CKD model: 90 min ischemia, 38 rats). Saline was infused in place of PTX or/and MP depending on the group. Renal function (diuresis, serum creatinine, creatinine clearance, sodium and potassium excretion, and urine protein/creatinine) was assessed at 48 h and 120 h post-IRI (AKI model) or 4, 16 and 24 weeks after IRI, along with survival analysis (CKD model). More evidently at early stages of AKI or CKD, treated animals showed higher glomerular filtration and diminished tubular loss of electrolytes, more so with PTX + MP than PTX or MP (serum creatinine (µmol/L) at 48 h of AKI: 60.9 ± 19.1 vs. 131.1 ± 94.4 vs. 233.4 ± 137.0, respectively, vs. 451.5 ± 114.4 in controls, all p < 0.05; and at 4 weeks of CKD: 89.0 ± 31.9 vs. 118.1 ± 64.5 vs. 156.9 ± 72.6, respectively, vs. 222.9 ± 91.4 in controls, p < 0.05 for PTX or PTX + MP vs. controls and PTX + MP vs. MP). Survival was better by >2-fold with PTX + MP (89%) vs. controls (40%; p < 0.05). PTX + MP largely protect from IRI-induced AKI and CKD and subsequent mortality in rats. This calls for clinical investigations, especially in kidney transplantation.


Assuntos
Injúria Renal Aguda/tratamento farmacológico , Glucocorticoides/uso terapêutico , Rim/fisiopatologia , Metilprednisolona/uso terapêutico , Pentoxifilina/uso terapêutico , Traumatismo por Reperfusão/tratamento farmacológico , Vasodilatadores/uso terapêutico , Animais , Glucocorticoides/administração & dosagem , Rim/irrigação sanguínea , Masculino , Metilprednisolona/administração & dosagem , Pentoxifilina/administração & dosagem , Ratos , Ratos Sprague-Dawley , Vasodilatadores/administração & dosagem
2.
Przegl Lek ; 69(4): 157-62, 2012.
Artigo em Polonês | MEDLINE | ID: mdl-23029710

RESUMO

The U.S. prevalence of obesity increases since the mid-70s of the 20th century. Around that time high-fructose corn syrup (HFCS)--mixture of fructose and glucose was introduced as a sweetener replacing sucrose in the food production. HFCS containing 55% fructose and 42-45% glucose (HFCS55) has dominated the American soft drink industry and HFCS has recently become commonly used in Poland. The coincidence of HFCS introduction and obesity epidemic raised widely publicized suspicions of a causal relationship between the two. As a possible mechanism, a higher content of fructose in the HFCS55, as compared with sucrose was suggested -fructose is known to increase serum uric acid level, induce hepatic lipogenesis and not stimulate postprandial hyperinsulinemia, a main activator of leptin release. Few comparative studies of HFCS and sucrose have largely failed to reveal any different impacts on the metabolic parameters, yet they were mainly short-term. It has been recently shown that obesity is linked with changes in the intenstinal flora. Among the causes of allegedly different effects of sucrose and HFCS on metabolism, their influence on the gut microbiome has not been examined. Some bacterial types do not hydrolyze sucrose which may determine different compositions of gut flora with the use of both sweeteners. Studies involving quantitative analysis of bacterial DNA in the stool, both in animals and in humans, shall shed light on the issue that has recently so much absorbed the U.S. public opinion.


Assuntos
Frutose/farmacologia , Glucose/farmacologia , Obesidade/epidemiologia , Obesidade/metabolismo , Edulcorantes/farmacologia , Animais , Causalidade , Fezes/microbiologia , Frutose/análise , Glucose/análise , Humanos , Intestinos/microbiologia , Lipogênese/efeitos dos fármacos , Fígado/metabolismo , Metagenoma/efeitos dos fármacos , Obesidade/etiologia , Prevalência , Edulcorantes/efeitos adversos , Edulcorantes/análise , Ácido Úrico/sangue
3.
Kidney Blood Press Res ; 36(1): 162-71, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23095255

RESUMO

BACKGROUND: Higher blood pressure and albuminuria are found in offspring of mothers who smoke during pregnancy. Whether or not kidney development is affected by maternal smoking is unknown. METHODS: Sprague-Dawley rats were randomly allocated to twice-daily cigarette smoke and nicotine condensate (1 mg/kg) or vehicle at day 10 of pregnancy until delivery. RESULTS: Exposed offspring did not differ from control offspring with respect to body weight, kidney weight, albuminuria, and creatinine clearance. Both male and female offspring had higher tail-plethysmographic blood pressures and lower mean glomerular volume, podocyte, mesangial-cell, and endothelial-cell number, compared to control offspring. CONCLUSIONS: The data document that prenatal exposure to cigarette-smoke condensate containing nicotine influences normal kidney development and could predispose to higher blood pressures later in life.


Assuntos
Animais Recém-Nascidos , Glomérulos Renais/anormalidades , Nicotina/efeitos adversos , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Fumar/efeitos adversos , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Contagem de Células , Feminino , Glomérulos Renais/patologia , Glomérulos Renais/fisiopatologia , Masculino , Modelos Animais , Nicotina/farmacologia , Tamanho do Órgão , Gravidez , Efeitos Tardios da Exposição Pré-Natal/patologia , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Ratos , Ratos Sprague-Dawley
4.
Przegl Lek ; 68(2): 107-13, 2011.
Artigo em Polonês | MEDLINE | ID: mdl-21751520

RESUMO

Hypercalciuria is the most common metabolic abnormality that causes urolithiasis. The pathogenetic mechanisms responsible for hypercalciuria include enhanced gastrointestinal absorption of calcium, increased bone resorption and/or decreased renal reabsorption of calcium; the main dietary factors promoting hypercalciuria are high dietary sodium intake and protein-rich diet. The authors discuss pathophysiology of hypercalciuria and genetic factors behind 'idiopathic hypercalciuria'. The simplified diagnostic approach to hypercalciuria is outlined herein, and available therapeutic interventions of proven efficacy in idiopathic hypercalciuria are presented as well. Dietary intervention for hypercalciuria should include reduced sodium, protein and oxalate intake. Thiazide diuretics, in conjunction with a low-sodium diet, tend to reduce urinary calcium excretion and ameliorate idiopathic hypercalciuria. Potassium citrate acts as an inhibitor of calcium stone formation in the urinary tract. A low-calcium diet should generally be avoided, as it may increase urinary oxalate excretion and actually promote stone formation. In addition, a low-calcium diet may lead to negative calcium balance in subjects with hypercalciuria, and therefore increases the risk of osteopenia.


Assuntos
Cálcio/farmacocinética , Hipercalciúria/metabolismo , Hipercalciúria/terapia , Doenças Ósseas Metabólicas/prevenção & controle , Reabsorção Óssea/metabolismo , Reabsorção Óssea/prevenção & controle , Cálcio/urina , Proteínas Alimentares/efeitos adversos , Humanos , Hipercalciúria/diagnóstico , Hipercalciúria/etiologia , Absorção Intestinal , Rim/metabolismo , Oxalatos/administração & dosagem , Inibidores de Simportadores de Cloreto de Sódio/uso terapêutico , Sódio na Dieta/efeitos adversos
5.
J Clin Endocrinol Metab ; 90(2): 864-70, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15572418

RESUMO

Familial benign hypocalciuric hypercalcemia (FBHH), in which calcium homeostasis is disordered, can be distinguished from mild primary hyperparathyroidism by the finding of a heterozygous loss-of-function mutation in the calcium-sensing receptor (CaSR). Here, we report a Polish kindred with FBHH, the proband of which had undergone an unsuccessful parathyroidectomy. Direct sequence analysis of exon 4 of her CASR gene identified a heterozygous R227Q mutation in the extracellular domain of the receptor. This mutation segregated with other affected family members. A de novo heterozygous R227L mutation had previously been identified in a case of neonatal hyperparathyroidism. We performed a functional analysis by transiently transfecting wild-type and mutant (R227Q, R227L) CaSRs in human embryonic kidney (HEK293) cells. Both mutant receptors were expressed at a similar level to that of the wild-type, demonstrated a 160-kDa molecular species consistent with having undergone full maturation, and were visualized on the cell surface. Although both mutants were impaired in their MAPK responses to increasing extracellular calcium concentrations relative to wild type, this was more marked for R227L (EC(50) = 9.7 mM) than R227Q (EC(50) = 7.9 mM) relative to wild type (EC(50) = 3.7 mM). When cotransfected with wild-type CaSR to mimic the heterozygous state, the curves for both R227Q and R227L were right shifted intermediate to the curves for wild type and the respective mutant. This differential responsiveness may account, in part, for the markedly different clinical presentation of the R227Q mutation, classic FBHH, vs. the neonatal hyperparathyroidism of the R227L mutation.


Assuntos
Códon/genética , Hipercalcemia/genética , Hiperparatireoidismo/genética , Polimorfismo de Nucleotídeo Único/genética , Receptores de Detecção de Cálcio/genética , Substituição de Aminoácidos , Sequência de Bases , Cálcio/sangue , DNA Complementar/genética , Feminino , Humanos , Magnésio/sangue , Masculino , Pessoa de Meia-Idade , Linhagem , Fosfatos/sangue
6.
Pol Arch Med Wewn ; 113(5): 466-70, 2005 May.
Artigo em Polonês | MEDLINE | ID: mdl-16479830

RESUMO

Osteopoikilosis is a rare, hereditary disorder of bone tissue. Most frequently this abnormality is asymptomatic and diagnosed incidentally on the basis of X-ray images, taken on other occasions. The characteristic radiographic appearance consists of oval or round, well-defined osteosclerotic foci in various sites of skeleton (pelvis, hands and feet, epiphyses of long bones). In the present paper a case of inborn osteopoikilosis in 23-year-old female patient is described. Typical bone abnormalities founding in her mother implicate an inherited character of this disorder.


Assuntos
Osso e Ossos/anormalidades , Osteopecilose/congênito , Osteopecilose/diagnóstico por imagem , Adulto , Osso e Ossos/diagnóstico por imagem , Feminino , Humanos , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...